Litigation Details for Forest Laboratories v. Amerigen Pharmaceuticals Inc. (D. Del. 2014)
✉ Email this page to a colleague
Forest Laboratories v. Amerigen Pharmaceuticals Inc. (D. Del. 2014)
| Docket | ⤷ Subscribe | Date Filed | 2014-10-03 |
| Court | District Court, D. Delaware | Date Terminated | 2015-10-23 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | Defendant | Referred To | |
| Patents | 8,168,209; 8,173,708; 8,283,379; 8,329,752; 8,362,085; 8,598,233 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Forest Laboratories v. Amerigen Pharmaceuticals Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Subscribe and ⤷ Subscribe .
Details for Forest Laboratories v. Amerigen Pharmaceuticals Inc. (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2016-02-14 | 133 | of a number of patents by Amerigen, including, among others, U.S. Patent Nos. 8,168,209; 8,173,708; 8,…8,362,085; and 8,598,233 (hereinafter, “the Adamas Patents”), based on Amerigen’s submission of Abbreviated…asserting infringement of, inter alia, the Adamas Patents, based on certain amendments to the subject ANDA…among other things, the invalidity of the Adamas Patents. (See D.I. 158 in C.A. No. 14-cv-121-LPS). Thereafter… Order, holding claims of each of the Adamas Patents invalid under 35 U.S.C. § 112 for indefiniteness | External link to document | |
| 2014-10-03 | 4 | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,039,009 B2; 8,168,209 B2; 8,173,708…; 8,362,085 B2; 8,598,233 B2. (Attachments: # 1 Patent/Trademark Report additional)(aah) (Entered: 10/…2014 23 October 2015 1:14-cv-01271 830 Patent Defendant District Court, D. | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
